Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Key Market Feature
1.4 Market Outline
1.5 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Application
6.1 Proteomics Applications
6.1.1 Gel Extraction
6.1.2 Western Blotting
6.1.3 Others
6.2 Nucleic Acid Applications
6.2.1 Sequencing
6.2.2 Northern Blotting
6.2.3 Southern Blotting
6.2.4 Molecular Cloning
6.2.5 Polymerase Chain Reaction (PCR)
6.2.6 Others
6.3 Protein Applications
Chapter 7 Market Segmentation by Market Type
7.1 Unstained Markers
7.2 Prestained Markers
7.3 Speciality Markers
Chapter 8 Market Segmentation by Product Type
8.1 RNA Markers
8.2 DNA Markers
8.3 Protein Markers
Chapter 9 Market Segmentation by End User
9.1 Pharmaceutical and Biotechnology Companies
9.2 Contract Research Organizations
9.3 Academic Research Institutions
9.4 Others
Chapter 10 Market Segmentation by Geography
10.1 Asia Pacific
10.1.1 Introduction
10.1.2 China
10.1.3 India
10.1.4 Japan
10.1.5 Australia & New Zealand
10.1.6 Others
10.2 North America
10.2.1 Introduction
10.2.2 United States
10.2.3 Canada
10.2.4 Mexico
10.2.5 Others
10.3 Europe
10.3.1 Introduction
10.3.2 Spain
10.3.3 UK
10.3.4 France
10.3.5 Russia
10.3.6 Italy
10.3.7 Others
10.4 The Middle East and Africa
10.4.1 Introduction
10.4.2 South Africa
10.4.3 Middle East Countries
10.4.4 Others
10.5 South America
10.5.1 Introduction
10.5.2 Argentina
10.5.3 Brazil
10.5.4 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company profiles
12.1 Roche
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Key Strategy
12.1.4 Recent Developments
12.2 Agilent Technologies
12.3 Thermo Fisher Scientific Inc.
12.4 Vmr International
12.5 Sigma-Aldrich
12.6 Takara Bio Inc.
12.7 Qiagen
12.8 New England Biolabs
12.9 Promega Corporation
12.10 Bio-Rad Laboratories
12.11 Affymetrix, Inc.
12.12 Merck Kgaa
Chapter 13 Market Estimates and Forecasts
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Application 2018-2024 (USD Million)
13.1.2 Market Estimation and Forecast by Market Type 2018-2024 (USD Million)
13.1.3 Market Estimation and Forecast by Product Type 2018-2024 (USD Million)
13.1.4 Market Estimation and Forecast by End User 2018-2024 (USD Million)
13.1.5 Market Estimation and Forecast by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
